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Here we report the case of a 20-year-old female patient
previously diagnosed with Hashimoto's thyroiditis and overt
hypothyroidism, and who had been taking synthetic thyroxine
(100 g/day) for eight months. She experienced intermittent μ
dizziness and generalized weakness, and was diagnosed as
having severe autoimmune hemolytic anemia (AIHA). We
prescribed prednisolone treatment and continued synthetic
thyroxine administration. Two years and five months later,
she developed idiopathic thrombocytopenic purpura (ITP) and
was diagnosed with Evans' syndrome. Thereafter, laparoscopic
splenectomy was performed because her autoimmune hemo-
lytic anemia was refractory and dependent on steroid therapy.
The HLA genotypes of the patient were HLA-A*020101/A*
2602, HLA-B*270502/B*5401, HLA-Cw*0102/Cw*020202,
HLA-DRB1*0404/DRB1*0405, and HLA-DQB1*0302/DQ
B1*0401. Hashimoto's thyroiditis is often associated with
other nonendocrine autoimmune diseases, and antithyroid
antibodies are frequently observed in Evans' syndrome (coex-
istence of AIHA and ITP). However, there is no report of
Evans' syndrome developing in patients with overt hypo-
thyroidism and Hashimoto's thyroiditis. This case suggests
that three autoimmune diseases (AIHA, ITP, and Hashimoto's
thyroiditis) might share a common immunogenetic pathway
in pathogenesis.
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INTRODUCTON
Chronic, autoimmune thyroid diseases are some-
times combined with autoimmune hematologic
diseases, such as pernicious anemia, autoimmune
hemolytic anemia (AIHA) and idiopathic throm-
bocytopenic purpura (ITP). Hashimoto's thyroid-
itis is one of the most common autoimmune
diseases. It is supported by autoantibody forma-
tion and lymphocyte infiltration of the thyroid
glands. Since Evans reported the first case of
AIHA associated with ITP, there have been sev-
eral case reports of Evans' syndrome occurring
simultaneously with an autoimmune thyroid
disease
1; nine cases of Evans' syndrome occurring
with Graves' disease have been reported,
2-10 and
one case of Evans' syndrome with Hashimoto's
thyroiditis and hypothyroidism has been reported
worldwide.
11 Here we report a case of Evans'
syndrome developed together with Hashimoto's
thyroiditis and overt hypothyroidism in a 20-year-
old woman.
CASE REPORT
A 20-year-old female patient, who had taken
synthetic thyroxine (100 g/day) for Hashimoto's μ
thyroiditis and overt hypothyroidism, was admit-
ted to our hospital with symptoms of dizziness
and generalized weakness in October 1997. Eight
months prior, she had been diagnosed with pri-
mary hypothyroidism and had begun treatment
with synthetic thyroxine (50 g/day). Upon ad μ -
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mission to our hospital, the patient had aggra-
vated dizziness with accompanying nausea and
vomiting. She has five siblings, none of whom has
any autoimmune disorder.
On physical examination, the patient's blood
pressure was 100/70 mmHg, body temperature,
36.8 , respiration rate, 20 breaths/minute, and
pulse rate, 110/minute. She weighed 51 kg and
measured 151 cm height (body mass index 22.4
kg/m
2).
She looked pale and acutely ill, and had anemic
conjunctiva and icteric sclera. Exophthalmoses
were not present. The thyroid gland was slightly
enlarged and had a hard consistency on palpation,
without tenderness. The abdomen was soft and
flat, and the liver and spleen were not palpable.
The patient's initial hemoglobin (5.2 g/dL) and
hematocrit (15.1%) levels were severely low. Her
white blood cell count (WBC) was 9,150/ L (68% μ
polymorphonuclear leukocytes, 18% lymphocytes,
12% monocytes and 2% metamyelocytes), and her
platelet count was 576,000/ L. The reticulocyte μ
count was 21.2%, the corrected reticulocyte count
was 7.0% and the reticulocyte index was 2.8.
Peripheral blood smear analysis revealed sphero-
cytosis, macrocytosis, poikilocytosis, and poly-
chromasia with hemolytic features, and adequate
white blood cell and platelet counts (Fig. 1).
Levels of both serum calcium and phosphorus
were within normal ranges. Total bilirubin, alka-
line phosphatase, aspartate transferase and ala-
nine transferase in the serum were 61.2 mol/dL μ
(reference range [RR], 5.1-17), 87 IU/L (RR, 30-
120), 45 and 62 U/L (RR, 5-45), respectively. Lac-
tate dehydrogenase concentration was highly in-
creased to 748 IU/L (RR, 30-170 IU/L), and serum
haptoglobin was decreased to 11.8 ng/dL (RR, 50-
320 ng/dL). Direct/indirect Coombs' tests and a
hemosiderin test yielded strongly positive results.
Antinuclear antibody (ANA), antiplatelet anti-
body, acidified sucrose lysis (Ham's) test and
osmotic fragility test were all negative. Abdominal
ultrasonography revealed that the patient had a
normal sized spleen and liver. According to bone
marrow aspiration and biopsy, the patient showed
erythroid hyperplasia, which is consistent with
hemolytic anemia.
The thyroid function tests performed during
synthetic thyroxine (100 μg/day) treatment showed
that the patient was at a euthyroid state. How-
ever, she had elevated levels of antithyroid anti-
bodies [antithyroglobulin antibody 3,100 U/mL
(RR, 0-60) and antimicrosomal antibody 541
U/mL (RR, 0-60)]. The technetium-99m scan (Fig.
2) indicated that she had a slightly enlarged
thyroid with an inhomogeneous uptake pattern
(2.8%). Based on the above results, the patient was
diagnosed as having autoimmune hemolytic
anemia and Hashimoto's thyroiditis. Her HLA
genotypes, HLA-A*020101/A*2602, HLA-B*270502/
B*5401, HLA-Cw*0102/Cw*020202, HLA DRB1*0404
/DRB1*0405, and DQB1*0302/DQB1*0401 were
determined as previously described.
12
Fig. 1. Peripheral blood smear on admission. The periphe-
ral blood smear shows typical hemolytic anemia features
such as spherocytosis, poikilocytosis, macrocytosis, and
polychromasia of red blood cells, and shows normal
findings for white blood cells and platelets (Wright stain,
×400).
Fig. 2. The technetium-99m thyroid scan. The thyroid
gland is slightly enlarged with an inhomogenous uptake
pattern. Uptake ratio of the thyroid gland is 2.8%.Mi Yeon Kang, et al.
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We started the patient on an oral administra-
tion of prednisolone (1 mg/kg) and continued
synthetic thyroxine medication (100 g/day). Her μ
hemoglobin level increased and stabilized within
two weeks after prednisolone treatment. She had
regular follow-up with prednisolone (10 to 30mg/
day) and synthetic thyroxine (100 g/day) for two μ
years and five months. In April 2000, she com-
plained of frequent epistaxis episodes and an
increased amount of menstrual bleeding with her
regular cycle. She denied ingestion of any drugs
including alcohol or herbs during that time
period. She had also adhered to the prescribed
administration of prednisolone and synthetic thy-
roxine. Physical examination did not show any
clues indicating systemic lupus erythematosus
(SLE) such as arthritis, photosensitivity, oral ulcer,
skin rash or psychosis. At that time, she had mo-
derate and persisting thrombocytopenia (75,000-
90,000/μL), and repeated ANA test results were
negative for serum platelet autoantibody. Hepa-
tosplenomegaly was not found by abdominal
ultrasonography. Bone marrow biopsy showed
normal findings, except a mildly increased num-
ber of megakaryocytes. Serum calcium, phos-
phorus and albumin were 2.3 mmol/L (RR 2.2-
2.6), 1.3 mmol/L (RR, 1.0-1.4) and 4.1 g/dL (3.2-
5.3), respectively. Her fasting serum glucose level
was 4.8 mmol/L. On urinalysis, neither proteinuria
nor microscopic hematuria were found.
Considering the occurrence of thrombocyto-
penia, and regardless of the prednisolone treat-
ment for AIHA and a normal bone marrow
biopsy, we concluded that she had refractory
Table 1. Laboratory Findings on Admission and Two Months before Splenectomy
Parameters Reference range October 3, 1997 July 11, 2000
White blood cell ( L) μ 4,000 - 9,000 9,150 10,680
Hemoglobin (g/dL) 12 - 16 5.2 8.0
Hematocrit (%) 36 - 48 15.1 22
Platelet (×10
3/μL) 140 - 400 576 68.9
MCV (fL) 79 - 96 122.3 108
MCH (pg) 26 - 32 42.6 36
MCHC (g/dL) 32 - 36 34.8 33
Reticulocyte count (%) 0.5 - 1.5 21.2 NC
Total bilirubin (mg/dL) 0.2 - 1.3 3.6 2.8
Alkaline phosphatase (IU/L) 30 - 120 87 44
Aspartate transferase (U/L) 5 - 45 62 31
Alanine transferase (U/L) 5 - 45 62 26
LDH (IU/L) 30 - 170 748 NC
Haptoglobin (ng/dL) 50 - 320 11.8 25.2
Antiplatelet antibody negative negative negative
Direct Coombs’ test negative 3+ 2+
Indirect Coombs’ test negative 3+ 2+
TSH (mIU/L) 0.17 - 4.05 1.74 0.74
Free thyroxine (ng/dL) 0.95 - 2.23 1.24 1.85
Free triiodothyronine (pg/mL) 1.6 - 3.8 3.19 2.94
Antithyroglobulin antibody (U/mL) < 60.00 153.01 > 2,000
Antimicrosomal antibody (U/mL) < 60.00 27.07 571.02
TSH-receptor antibody (IU/L) 0.0 - 1.00 NC 45.17
MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; LDH,
lactate dehydrogenase; TSH, thyroid stimulating hormone; NC, not checked.Evans' Syndrome and Hashimoto's Thyroiditis
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idiopathic thrombocytopenic purpura and autoim-
mune hemolytic anemia, called Evans' syndrome,
associated with Hashimoto's thyroiditis. The
severity of hemolytic anemia fluctuated with pre-
dnisolone dosage, so we were not able to lower
her prednisolone dosage below 20 mg/day. In
July 2000, the patient had shown aggravated
hemolytic anemia, despite a prednisolone dosage
of over 30 mg/day. We concluded that the patient
was in a steroid dependent and steroid refractory
state, and so carried out a laparoscopic splenec-
tomy.
After the operation, the patient's hemoglobin
level and platelet count were restored to 11.1 g/
dL and 461,000/µL, respectively. We could then
lower her prednisolone dosage to 10 mg/day.
Currently, she is still taking 10 mg of predniso-
lone per day due to her steroid-dependent AIHA
and ITP condition, and has regular follow-ups at
our hospital's outpatient clinic.
DISCUSSION
In a previous study,
13 the prevalence of anti-
thyroid antibodies in Evans' syndrome (25%,
5/20) was higher than that in AIHA (11.4%, 5/44)
or in ITP (0%, 0/20). In addition, the incidence of
subclinical hypothyroidism in Evans' syndrome
was 20% (4/20), while it was 20.4% in AIHA
(9/44) and 5% in ITP (1/20). Graves' disease was
reported as being concomitant with Evans' syn-
drome in 10% (2/20) of cases, concomitant with
AIHA in 0% (0/44) of cases, and with ITP in 5%
(1/20) of cases. These findings indicate that tests
for abnormal thyroid function and autoimmune
thyroiditis are often affected by AIHA, ITP and
Evans syndrome. Furthermore, patients with Evans'
syndrome more frequently experience autoim-
mune thyroiditis complications than those with
only AIHA or ITP. This suggests that Evans' syn-
drome might be associated with a specific gene,
which may amplify the autoimmune response in
the thyroid gland.
There are two distinct types of autoimmune
polyendocrine syndromes with characteristic clini-
cal manifestations. APS (autoimmune polyendo-
crine syndrome) type I, typically recognized in
early childhood, is a rare autosomal, recessive
disorder. Defects in the autoimmune regulator
gene have been shown to cause this disorder.
14 In
contrast, the more common syndrome, APS type
II, typically manifesting in adulthood, has poly-
genic inheritance. APS type II is less well defined,
but is strongly associated with several specific
HLA class II gene polymorphisms, frequently
HLA DR0301-DQB1*0201, DRB1*0402-, 0404- or
0405-DQB1*0302.
15 The chronic development of
organ-specific autoimmunity necessitates the eval-
uation of patients with Evans' syndrome over
time. Hashimoto's thyroiditis and Evans' syn-
drome are autoimmune disorders,
16 yet the com-
bined disorders have still not been classified in
APS. In this case, HLA DRB1*0404-DQB1*0302
and DRB1*0405-DQB1*0401 haplotypes were com-
mon HLA subtypes associated with APS type II.
This suggests further that autoimmune hemolytic
anemia and idiopathic thrombocytopenic purpura
with Hashimoto's thyroiditis might share a com-
mon pathogenetic pathway, the defect of which
leads to Evans' syndrome and should be classified
as an APS type.
In summary, we report a case of Hashimoto's
thyroiditis complicated by Evans' syndrome, and
suggest that Evans' syndrome could be a high risk
factor for autoimmune thyroiditis. Patients with
Evans' syndrome should be evaluated by thyroid
function tests, including those for thyroid auto-
antibodies, to prevent the development of overt
hypo- or hyperthyroidism. Although the precise
pathogenetic mechanism in Hashimoto's thyroi-
ditis and Evans' syndrome remains to be deter-
mined, the two diseases might share a common
pathway.
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